Literature DB >> 4050698

Primary acute pericardial disease: a prospective series of 231 consecutive patients.

G Permanyer-Miralda, J Sagristá-Sauleda, J Soler-Soler.   

Abstract

A series of 231 patients with "primary" acute pericardial disease (acute pericarditis or tamponade presenting without an apparent cause) were studied according to the following protocol: general clinical and laboratory studies (stage I), pericardiocentesis (stage II), pericardial biopsy (stage III) and blind antituberculous therapy (stage IV). In 32 patients (14%) a specific etiologic diagnosis was obtained (13 with neoplasia, 9 with tuberculosis, 4 with collagen vascular disease, 2 with toxoplasmosis, 2 with purulent pericarditis and 2 with viral pericarditis). "Diagnostic" pericardiocentesis (32 patients) was performed when clinical activity and effusion persisted for longer than 1 week or when purulent pericarditis was suspected, whereas "therapeutic" pericardiocentesis (44 patients) was performed to treat tamponade; their diagnostic yield was 6% and 29%, respectively. "Diagnostic" biopsy (20 patients) was carried out when illness persisted for longer than 3 weeks, whereas "therapeutic" biopsy was performed whenever pericardiocentesis failed to relieve tamponade; their diagnostic yield was 5% and 54%, respectively. The diagnostic yield difference between "diagnostic" and "therapeutic" procedures was significant (p less than 0.001); in contrast, the global diagnostic yield of pericardiocentesis (19%) and biopsy (22%) was similar. At the end of follow-up (1 to 76 months, mean 31 +/- 20), no patient in whom a diagnosis of idiopathic pericarditis had been made showed signs of pericardial disease. It is concluded that a "diagnostic" procedure is not warranted as a routine method, a choice between "therapeutic" pericardiocentesis and biopsy is circumstantial and must be individualized, and only through a systematic approach can a substantial diagnostic yield be reached in primary acute pericardial disease.

Entities:  

Mesh:

Year:  1985        PMID: 4050698     DOI: 10.1016/0002-9149(85)91023-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  42 in total

Review 1.  Management of pericardial effusion.

Authors:  J Soler-Soler; J Sagristà-Sauleda; G Permanyer-Miralda
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

Review 2.  Pericardial constriction: uncommon patterns.

Authors:  J Sagristà-Sauleda
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 3.  Acute pericardial disease: approach to the aetiologic diagnosis.

Authors:  G Permanyer-Miralda
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 4.  Relapsing pericarditis.

Authors:  Jordi Soler-Soler; Jaume Sagristà-Sauleda; Gaietà Permanyer-Miralda
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

5.  Pleuritic chest pain in a patient who had undergone recent surgical repair of a patent foramen ovale.

Authors:  Todd A Seigel; Jason W Ryan; Michael M Woodruff
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

6.  Pericardial disease: what the general cardiologist needs to know.

Authors:  Emma L Ivens; Bradley I Munt; Robert R Moss
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

7.  Sudden death due to cardiac tamponade from malignant pericardial involvement by metastatic lung cancer.

Authors:  Robert Cassady; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2014-10-19       Impact factor: 2.007

8.  Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality.

Authors:  Kirstine Kobberøe Søgaard; Dóra Körmendiné Farkas; Vera Ehrenstein; Krishnan Bhaskaran; Hans Erik Bøtker; Henrik Toft Sørensen
Journal:  Circulation       Date:  2017-06-29       Impact factor: 29.690

9.  An unusual presentation of staphylococcal pericarditis.

Authors:  S Wieshammer; M Bode; L Weber; P Weismüller; T Binder; H Seibold; V Hombach
Journal:  Klin Wochenschr       Date:  1990-04-17

Review 10.  Common emergencies in cancer medicine: cardiovascular and neurologic syndromes.

Authors:  C R Thomas; E A Edmondson
Journal:  J Natl Med Assoc       Date:  1991-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.